BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
151 hedge funds and large institutions have $251M invested in BioDelivery Sciences International, Inc. in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 39 reducing their positions, and 19 closing their positions.
503% more call options, than puts
Call options by funds: $1.58M | Put options by funds: $262K
37% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 19
31% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 39
4% more funds holding
Funds holding: 145 → 151 (+6)
12% less capital invested
Capital invested by funds: $284M → $251M (-$32.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$7.94M |
| 2 |
Goldman Sachs
New York
|
+$4.46M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.29M |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
+$3.78M |
| 5 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$3.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$21.5M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$14.8M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$4.93M |
| 4 |
1CM
1492 Capital Management
Milwaukee,
Wisconsin
|
-$3.32M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$2.45M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
151
Penn Capital Management
Philadelphia,
Pennsylvania
| – | -$1.58M | -376,363 | Closed |
|
|
DMK
152
David M. Knott
| – | -$1.55M | -370,230 | Closed |
|
153
Marshall Wace
London,
United Kingdom
| – | -$477K | -113,584 | Closed |
|
|
OAM
154
Oberweis Asset Management
Lisle,
Illinois
| – | -$372K | -88,600 | Closed |
|
155
Citadel Advisors
Miami,
Florida
| – | -$301K | -72,865 | Closed |
|
|
SGAM
156
Smith Group Asset Management
Dallas,
Texas
| – | -$265K | -63,049 | Closed |
|
157
Group One Trading
Chicago,
Illinois
| – | -$72.3K | -17,502 | Closed |
|
|
VF
158
Virtu Financial
New York
| – | -$70K | -16,593 | Closed |
|
|
CSM
159
CAMG Solamere Management
Charlotte,
North Carolina
| – | -$50K | -11,699 | Closed |
|
160
Rafferty Asset Management
New York
| – | -$47K | -11,146 | Closed |
|
161
Walleye Trading
New York
| – | -$42K | -10,102 | Closed |
|
|
TFA
162
Toth Financial Advisory
Leesburg,
Virginia
| – | -$8K | -2,000 | Closed |
|
|
CWP
163
Concord Wealth Partners
Abingdon,
Virginia
| – | -$4K | -1,045 | Closed |
|
|
GWS
164
Glassman Wealth Services
Vienna,
Virginia
| – | +$116 | +28 | New |
|
BDSI Hedge Fund Activity: Q1 2021 in Review
151 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2021, worth a combined $251M — down 12% from $284M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new BDSI positions and 19 closed out — a net gain of 7 holders — while 51 added to existing stakes and 39 trimmed.
The largest buyer was Royce & Associates, opening a new position worth an estimated $7.94M. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $21.5M sold.
- 151 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2021, up from 145 in Q4 2020.
- Funds reported $251M of BioDelivery Sciences International, Inc. stock for Q1 2021, down 12% quarter-over-quarter.
- 26 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2021 and 19 closed out, a net change of +7 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q1 2021 was Royce & Associates, an estimated $7.94M added.
- The largest BioDelivery Sciences International, Inc. seller in Q1 2021 was Nantahala Capital Management, an estimated $21.5M sold.
Based on aggregated 13F filings for Q1 2021.